MEGAN DAILEY: Open Payments
NPI 1013695014 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 31 payments from 17 companies in 2025. Trend: 2023 $20 · 2024 $1,251 · 2025 $878
Food & beverage: $878
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $166 |
| Geron Corporation | 1 | $116 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| Janssen Biotech, Inc. | 3 | $81 |
| E.R. Squibb & Sons, L.L.C. | 2 | $78 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| SOBI, INC | 1 | $35 |
| GENZYME CORPORATION | 1 | $34 |
| Astellas Pharma US Inc | 1 | $31 |
| Coherus Oncology, Inc. | 1 | $31 |
Products named: DATROWAY, RYTELO, KISQALI, OPDIVO, CARVYKTI, KEYTRUDA, Gamifant, AYVAKIT.
Industry payments across DC — which companies pay providers there.
